| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| holding | BLFS | Common Stock | 5,089 | 02 Dec 2024 | Direct | F1 |
| Id | Content |
|---|---|
| F1 | The amount represented in Column 2 of Table I includes 992 shares of the Company's common stock granted on September 9, 2021 pursuant to the BioLife Solutions 2013 Performance Incentive Plan, as amended (the "Plan"), which vests in equal quarterly installments, and 4,097 shares of restricted stock granted on February 24, 2022 pursuant to the Plan, which vests in equal quarterly installments. |